Table 1 Chi-square analysis between PRKG1-AS1 and clinicopathological indicators
From: Long non-coding RNA PRKG1-AS1 promotes cell proliferation and migration in lung adenocarcinoma
Clinical factors | PRKG1-AS1 expression | P value | |
|---|---|---|---|
Low | High | ||
Vital status | 0.004** | ||
Alive | 164(73.2) | 135(60.3) | |
Dead | 60 (26.8) | 89(39.7) | |
Gender | 0.570 | ||
Female | 123(54.9) | 117(52.2) | |
Male | 101(45.1) | 107(47.8) | |
Age (years) | 0.006** | ||
≤ 65 | 121(54.0) | 92(41.1) | |
> 65 | 103(46.0) | 132 (58.9) | |
Stage | 0.272 | ||
I | 125(55.8) | 116 (51.8) | |
II | 58(25.9) | 53(23.7) | |
III/IV | 41(18.3) | 55(24.6) | |
Tumor stage | 0.366 | ||
T1 | 73(32.6) | 78(34.8) | |
T2 | 127(56.7) | 114(50.9) | |
T3/4 | 34(10.7) | 32(14.3) | |
Node metastasis | 0.835 | ||
N0 | 150(67.0) | 144(64.3) | |
N1 | 42(18.8) | 45(20.1) | |
N2 | 32(14.3) | 35(15.6) | |